SK283075B6 - Deriváty 4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamidu a farmaceutický prostriedok, ktorý ich obsahuje - Google Patents

Deriváty 4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamidu a farmaceutický prostriedok, ktorý ich obsahuje Download PDF

Info

Publication number
SK283075B6
SK283075B6 SK129-2000A SK1292000A SK283075B6 SK 283075 B6 SK283075 B6 SK 283075B6 SK 1292000 A SK1292000 A SK 1292000A SK 283075 B6 SK283075 B6 SK 283075B6
Authority
SK
Slovakia
Prior art keywords
mmol
dihydro
pyridazino
methyl
indole
Prior art date
Application number
SK129-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK1292000A3 (en
Inventor
Yannick Evanno
Laurent Dubois
Mireille Sevrin
Frank Marguet
Jacques Froissant
R�Gine Bartsch
Catherine Gille
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SK1292000A3 publication Critical patent/SK1292000A3/sk
Publication of SK283075B6 publication Critical patent/SK283075B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
SK129-2000A 1997-07-30 1998-07-28 Deriváty 4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamidu a farmaceutický prostriedok, ktorý ich obsahuje SK283075B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709692A FR2766823B1 (fr) 1997-07-30 1997-07-30 Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
PCT/FR1998/001667 WO1999006406A1 (fr) 1997-07-30 1998-07-28 DERIVES DE 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b] INDOLE-1-ACETAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (2)

Publication Number Publication Date
SK1292000A3 SK1292000A3 (en) 2000-08-14
SK283075B6 true SK283075B6 (sk) 2003-02-04

Family

ID=9509801

Family Applications (1)

Application Number Title Priority Date Filing Date
SK129-2000A SK283075B6 (sk) 1997-07-30 1998-07-28 Deriváty 4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamidu a farmaceutický prostriedok, ktorý ich obsahuje

Country Status (33)

Country Link
US (1) US6262045B1 (bg)
EP (1) EP1000063B1 (bg)
JP (1) JP4322421B2 (bg)
KR (1) KR100497782B1 (bg)
CN (1) CN1134440C (bg)
AR (1) AR013264A1 (bg)
AT (1) ATE226584T1 (bg)
AU (1) AU736600B2 (bg)
BG (1) BG64283B1 (bg)
BR (1) BR9811582B1 (bg)
CA (1) CA2298522C (bg)
CO (1) CO5210883A1 (bg)
CZ (1) CZ290011B6 (bg)
DE (1) DE69808921T2 (bg)
DK (1) DK1000063T3 (bg)
EE (1) EE04317B1 (bg)
ES (1) ES2186212T3 (bg)
FR (1) FR2766823B1 (bg)
HK (1) HK1028027A1 (bg)
HU (1) HU229430B1 (bg)
IL (1) IL133633A (bg)
NO (1) NO313963B1 (bg)
NZ (1) NZ502361A (bg)
PL (1) PL194245B1 (bg)
PT (1) PT1000063E (bg)
RU (1) RU2197490C2 (bg)
SI (1) SI1000063T1 (bg)
SK (1) SK283075B6 (bg)
TR (1) TR200000278T2 (bg)
TW (1) TW506971B (bg)
UA (1) UA57088C2 (bg)
WO (1) WO1999006406A1 (bg)
ZA (1) ZA986786B (bg)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788696B1 (fr) * 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
GB0000564D0 (en) 2000-01-11 2000-03-01 Merck Sharp & Dohme Therapeutic agents
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
NZ562559A (en) * 2005-05-05 2011-03-31 Sanofi Aventis Us Llc Stable nanoparticle formulations smaller than 1000 nm without the use of any surface modifier or stabilizzer absorbed onto the surface of the particles
CN101272767B (zh) * 2005-08-29 2012-08-29 赛诺菲-安万特美国有限责任公司 7-氯-N,N,5-三甲基-4-氧-3-苯基-3,5-二氢-4H-哒嗪并[4,5-b]吲哚-1-乙酰胺的无定形固体分散体
ZA200801890B (en) * 2005-08-29 2009-11-25 Sanofi Aventis Us Llc Novel crystalline form of a pyridazino (4, 5-B) indole derivative
CA2623026A1 (en) * 2005-09-23 2007-04-05 Schering Corporation Fused tetracyclic mglur1 antagonists as therapeutic agents
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
KR20110052640A (ko) * 2008-08-18 2011-05-18 사노피-아벤티스 유.에스. 엘엘씨 7-클로로-Ｎ,Ｎ,5-트리메틸-4-옥소-3-페닐-3,5-디하이드로-4Ｈ-피리다지노[4,5-ｂ]인돌-1-아세트아미드의 다형체의 제조방법
EP2181717A1 (en) 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985560A (en) * 1990-01-12 1991-01-15 American Home Products Corporation Pyridazino(4,5-b)indolizines
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
US5756501A (en) * 1995-12-13 1998-05-26 American Home Products Corporation Saturated and unsaturated pyridazino 4,5-B! indolizines useful as antidementia agents
FR2754262B1 (fr) 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
NZ502361A (en) 2001-06-29
BG104096A (bg) 2000-08-31
SK1292000A3 (en) 2000-08-14
CO5210883A1 (es) 2002-10-30
DK1000063T3 (da) 2003-02-24
ATE226584T1 (de) 2002-11-15
RU2197490C2 (ru) 2003-01-27
BG64283B1 (bg) 2004-08-31
ZA986786B (en) 1999-02-02
JP4322421B2 (ja) 2009-09-02
NO313963B1 (no) 2003-01-06
US6262045B1 (en) 2001-07-17
CA2298522C (en) 2008-07-15
UA57088C2 (uk) 2003-06-16
PT1000063E (pt) 2003-03-31
CN1265108A (zh) 2000-08-30
AR013264A1 (es) 2000-12-13
AU736600B2 (en) 2001-08-02
IL133633A (en) 2004-02-08
PL338445A1 (en) 2000-11-06
KR20010022356A (ko) 2001-03-15
PL194245B1 (pl) 2007-05-31
EE200000056A (et) 2000-10-16
EP1000063B1 (fr) 2002-10-23
DE69808921T2 (de) 2003-07-03
ES2186212T3 (es) 2003-05-01
TW506971B (en) 2002-10-21
HUP0002650A3 (en) 2002-09-30
EP1000063A1 (fr) 2000-05-17
BR9811582B1 (pt) 2010-10-19
EE04317B1 (et) 2004-06-15
TR200000278T2 (tr) 2000-08-21
HK1028027A1 (en) 2001-02-02
HUP0002650A2 (hu) 2001-01-29
BR9811582A (pt) 2000-09-26
NO20000462D0 (no) 2000-01-28
WO1999006406A1 (fr) 1999-02-11
FR2766823B1 (fr) 1999-10-08
CN1134440C (zh) 2004-01-14
CA2298522A1 (en) 1999-02-11
NO20000462L (no) 2000-03-29
FR2766823A1 (fr) 1999-02-05
KR100497782B1 (ko) 2005-06-27
JP2001512122A (ja) 2001-08-21
AU8983298A (en) 1999-02-22
CZ2000320A3 (cs) 2000-05-17
DE69808921D1 (de) 2002-11-28
IL133633A0 (en) 2001-04-30
HU229430B1 (en) 2013-12-30
SI1000063T1 (en) 2003-04-30
CZ290011B6 (cs) 2002-05-15

Similar Documents

Publication Publication Date Title
PL191489B1 (pl) Pochodna 2-arylo-8-oksodihydropuryny, sposób jej wytwarzania i jej zastosowanie, zawierająca ją kompozycja farmaceutyczna, zawierający ją środek do leczenia oraz zawierający ją środek przeciwlękowy
SK283075B6 (sk) Deriváty 4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamidu a farmaceutický prostriedok, ktorý ich obsahuje
CZ20002691A3 (cs) Triazolopyridazinové deriváty
EA004373B1 (ru) 1-АМИНОТРИАЗОЛО[4,3-a]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ IV
SK33995A3 (en) Imidazodiazepines
US6075021A (en) 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and application thereof in therapeutics
US20030018026A1 (en) Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
SK285307B6 (sk) Substituovaný derivát triazolopyridazínu, spôsob jeho výroby, farmaceutický prostriedok s jeho obsahom a jeho použitie
US5512590A (en) 5,6-dihydro-4h-imidazo 2',1':2,3!imidazo- 4,5,1-ij!quinoline and 4,5-dihydroimidazo- 1,2-a!pyrolo 1,2,3-cd!benzimidazole derivatives, their preparation and application in therapeutics
SK4694A3 (en) 9h-imidazo (1,2,-a) benzimidazole-3-acetamide derivatives method of their preparation and pharmaceutical compounds containing these derivatives
FI63405B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara imdazo(1,5-a)(1,4)diazepin-foereningar
MXPA00001009A (en) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20140728